INS and metabolic dysfunction-associated steatotic liver disease: Various factors, including lipotoxicity, the activation of systemic and local inflammatory and immune pathways, reactive oxygen species, insulin resistance, and the alterations in the gut bacterial flora, are associated with the pathogenesis of MASLD-associated HCC [18].